Page 113 of 141
Thailand faces a significant burden in terms of treating and managing degenerative and chronic diseases. Moreover, incidences of rare diseases are rising. Many of these—such as diabetes, cancer, and inherited ...
Interferon-γ (IFN-γ) is regarded as a potent antitumor agent, but its clinical application is limited by its short half-life and significant side effects. In this paper, we tried to develop IFN-γ gene therapy ...
The globular heads of the human C1q receptor (gC1qR) localize predominantly to the mitochondrial matrix. gC1qR mediates many biological responses, including growth perturbation, morphological abnormalities and...
Membrane-bound phospholipid scramblase 1 (PLSCR1) is involved in both lipid trafficking and cell signaling. Previously, we showed that PLSCR1 is overexpressed in many colorectal carcinomas (CRCs). In the prese...
High systemic estrogen levels contribute to breast cancer risk for postmenopausal women, whereas low levels contribute to osteoporosis risk. Except for obesity, determinants of non-ovarian systemic estrogen le...
Most DNA-damaging chemotherapeutic agents activate the transcription factor nuclear factor κB (NF-κB). However, NF-κB activation can either protect from or contribute to the growth suppressive effects of the a...
Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease characterized by B-cell hyper-reactivity and the production of pathogenic anti-nuclear-directed auto-antibodies (Abs). B-cell ontogeny is part...
The CD133 antigen is a marker of radio- and chemo-resistant stem cell populations in glioblastoma (GBM). The O6-methylguanine DNA methyltransferase (MGMT) enzyme is related with temozolomide (TMZ) resistance. Our...
Epidermal growth factor receptor (EGFR) is suggested to predict the radiosensitivity and/or prognosis of human esophageal squamous cell carcinoma (ESCC). The objective of this study was to investigate the effi...
The use of natalizumab in multiple sclerosis (MS) may favour JC virus reactivation; this phenomenon is usually asymptomatic but can, albeit rarely, evolve into frank progressive multifocal leucoencephalopathy ...
Multiple myeloma (MM) is a plasma cell malignancy with a multifaceted immune dysfunction. Indoleamine 2,3-dioxygenase 1 (IDO1) degrades tryptophan into kynurenine (KYN), which inhibits effector T cells and pro...
Multiple farnesylated proteins are involved in signal transduction in cancer. Farnesyltransferase inhibitors (FTIs) have been developed as a strategy to inhibit the function of these proteins. As FTIs inhibit ...
Dovitinib is a receptor tyrosine kinase (RTK) inhibitor targeting vascular endothelial growth factor receptors, fibroblast growth factor receptors and platelet-derived growth factor receptor β. Dovitinib is cu...
We tested whether apoptotic adipose-derived mesenchymal stem cells (A-ADMSCs) were superior to healthy (H)-ADMSCs at attenuating organ damage and mortality in sepsis syndrome following cecal ligation and punct...
Ischemia is the major cause of acute kidney injury (AKI), associated with high mortality and morbidity. Mesenchymal stem cells (MSCs) have multilineage differentiation potential and can be a potent therapeutic...
The secretory small GTPase Rab27b was recently identified as an oncogene in breast cancer (BC) in vivo and in vitro studies. This research was designed to further explore the clinical and prognostic significan...
Blood biomarkers are needed to monitor anti-angiogenic treatments for cancer. The association of blood levels of microRNAs (miRs) implicated in angiogenesis with circulating endothelial cells (CEC) and with an...
Disease biomarkers are defined to diagnose various phases of diseases, monitor severities of diseases and responses to therapies, or predict prognosis of patients. Disease-specific biomarkers should benefit dr...
The Retraction Note to this article has been published in Journal of Translational Medicine 2013 11:144
The physiological role of the neurotrophin nerve growth factor (NGF) has been characterized, since its discovery in the 1950s, first in the sensory and autonomic nervous system, then in central nervous, endocr...
This article is part of a Supplement: Volume 10 Supplement 3
This article is part of a Supplement: Volume 10 Supplement 3
This article is part of a Supplement: Volume 10 Supplement 3
This article is part of a Supplement: Volume 10 Supplement 3
This article is part of a Supplement: Volume 10 Supplement 3
This article is part of a Supplement: Volume 10 Supplement 3
This article is part of a Supplement: Volume 10 Supplement 3
This article is part of a Supplement: Volume 10 Supplement 3
This article is part of a Supplement: Volume 10 Supplement 3
This article is part of a Supplement: Volume 10 Supplement 3
This article is part of a Supplement: Volume 10 Supplement 3
This article is part of a Supplement: Volume 10 Supplement 3
This article is part of a Supplement: Volume 10 Supplement 3
This article is part of a Supplement: Volume 10 Supplement 3
This article is part of a Supplement: Volume 10 Supplement 3
This article is part of a Supplement: Volume 10 Supplement 3
This article is part of a Supplement: Volume 10 Supplement 3
This article is part of a Supplement: Volume 10 Supplement 3
This article is part of a Supplement: Volume 10 Supplement 3
This article is part of a Supplement: Volume 10 Supplement 3
This article is part of a Supplement: Volume 10 Supplement 3
This article is part of a Supplement: Volume 10 Supplement 3
This article is part of a Supplement: Volume 10 Supplement 3
This article is part of a Supplement: Volume 10 Supplement 3
This article is part of a Supplement: Volume 10 Supplement 3
This article is part of a Supplement: Volume 10 Supplement 3
This article is part of a Supplement: Volume 10 Supplement 3
This article is part of a Supplement: Volume 10 Supplement 3
This article is part of a Supplement: Volume 10 Supplement 3
This article is part of a Supplement: Volume 10 Supplement 3
This article is part of a Supplement: Volume 10 Supplement 3
2022 Citation Impact
7.4 - 2-year Impact Factor
6.9 - 5-year Impact Factor
1.458 - SNIP (Source Normalized Impact per Paper)
1.544 - SJR (SCImago Journal Rank)
2023 Speed
9 days submission to first editorial decision for all manuscripts (Median)
86 days submission to accept (Median)
2023 Usage
4,999,990 downloads
8,678 Altmetric mentions